MARGARET WEBB: Open Payments
NPI 1235739558 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,664 in 51 payments from 6 companies in 2025. Trend: 2023 $1,279 · 2024 $399 · 2025 $13,664
Speaker / faculty: $12,375Food & beverage: $753Travel & lodging: $537
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $13,277 |
| Alkermes, Inc. | 3 | $221 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: VRAYLAR, ARISTADA, LYBALVI, COBENFY, CAPLYTA, Auvelity, REXULTI.
Industry payments across MD — which companies pay providers there.
